Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: A systematic review and economic evaluation

C. Green, J. Dinnes, I. Takeda, J. Shepherd, D. Hartwell, C. Cave, E. Payne, B.H. Cuthbertson

    Research output: Contribution to journal › Article › peer-review

    31 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: A systematic review and economic evaluation'. Together they form a unique fingerprint.

    Keyphrases

    Nursing and Health Professions

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology